1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Blood Brain Barrier Technologies Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Blood Brain Barrier Technologies Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Blood Brain Barrier Technologies Market Regional Analysis
6.2 Europe Blood Brain Barrier Technologies Market Revenue 2019-2028 (US$ Million)
6.3 Europe Blood Brain Barrier Technologies Market Forecast Analysis
7. Europe Blood Brain Barrier Technologies Market Analysis – by Technology
7.1 Bispecific Antibody RMT Approach
- 7.1.1 Overview
- 7.1.2 Bispecific Antibody RMT Approach: Europe Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Trojan Horse Approach
- 7.2.1 Overview
- 7.2.2 Trojan Horse Approach: Europe Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Increasing Permeability
- 7.3.1 Overview
- 7.3.2 Increasing Permeability: Europe Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Passive Diffusion
- 7.4.1 Overview
- 7.4.2 Passive Diffusion: Europe Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.5 Other Non-Invasive BBB Technologies
- 7.5.1 Overview
- 7.5.2 Other Non-Invasive BBB Technologies: Europe Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe Blood Brain Barrier Technologies Market Analysis – by Application
8.1 Alzheimer's Disease
- 8.1.1 Overview
- 8.1.2 Alzheimer's Disease: Europe Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Epilepsy
- 8.2.1 Overview
- 8.2.2 Epilepsy: Europe Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Parkinson's Disease
- 8.3.1 Overview
- 8.3.2 Parkinson's Disease: Europe Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Multiple Sclerosis
- 8.4.1 Overview
- 8.4.2 Multiple Sclerosis: Europe Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Hunter's Syndrome
- 8.5.1 Overview
- 8.5.2 Hunter's Syndrome: Europe Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.6 Brain Cancer
- 8.6.1 Overview
- 8.6.2 Brain Cancer: Europe Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe Blood Brain Barrier Technologies Market – Europe Analysis
9.1 Overview
9.2 Europe
- 9.2.1 Europe Blood Brain Barrier Technologies Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 9.2.1.1 Europe Blood Brain Barrier Technologies Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 UK:
Europe Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 UK: Europe Blood Brain Barrier Technologies Market Breakdown, by Technology
- 9.2.1.1.2 UK: Europe Blood Brain Barrier Technologies Market Breakdown, by Application
- 9.2.1.2 Germany:
Europe Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Germany: Europe Blood Brain Barrier Technologies Market Breakdown, by Technology
- 9.2.1.2.2 Germany: Europe Blood Brain Barrier Technologies Market Breakdown, by Application
- 9.2.1.3 France:
Europe Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 France: Europe Blood Brain Barrier Technologies Market Breakdown, by Technology
- 9.2.1.3.2 France: Europe Blood Brain Barrier Technologies Market Breakdown, by Application
- 9.2.1.4 Russia:
Europe Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.4.1 Russia: Europe Blood Brain Barrier Technologies Market Breakdown, by Technology
- 9.2.1.4.2 Russia: Europe Blood Brain Barrier Technologies Market Breakdown, by Application
- 9.2.1.5 Italy:
Europe Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.5.1 Italy: Europe Blood Brain Barrier Technologies Market Breakdown, by Technology
- 9.2.1.5.2 Italy: Europe Blood Brain Barrier Technologies Market Breakdown, by Application
- 9.2.1.6 Rest of Europe:
Europe Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.6.1 Rest of Europe: Europe Blood Brain Barrier Technologies Market Breakdown, by Technology
- 9.2.1.6.2 Rest of Europe: Europe Blood Brain Barrier Technologies Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Teva Pharmaceutical Industries Ltd.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Eli Lilly and Company
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Bristol-Myers Squibb Company
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Pfizer, Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Johnson & Johnson Services, Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Fabre-Kramer Pharmaceuticals, Inc.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Bioasis Technologies, Inc.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Abliva AB.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For Europe Blood Brain Barrier Technologies Market
